CEREBRAL ATROPHY side effect
What is CEREBRAL ATROPHY ?Drugs associated with CEREBRAL ATROPHY
ADARTREL AKARIN ALTACE AMITIZA ANTABUSE ATROPINE AVONEX BACLOFEN BETASERON BISOPROLOL CACIT CAP CARBATROL CARBOPLATIN CELEBRA CIPRAMIL CIPROFLOXACIN CISPLATIN CITALOPRAM CLARITH CLOFARABINE CLOZAPINE COOLM CYCLOSPORINE DEPAKOTE DIAZEPAM EFFEXOR ENBREL ESCITALOPRAM ETOPOSIDE EXELON FLUDEX GLIADEL HUMULIN IMIPENEM ISONIAZID LORAZEPAM MEMANTINE METHADONE NEORAL OLANZAPINE PAROXETINE PAXIL PRAMIPEXOLE PREZISTA PROGRAF REBIF RENAGEL SEBIVO SERTRALINE TACROLIMUS TAXOL TAZOCILLINE THEOPHYLLINE TYSABRI VALTREX WARFARIN ZOLEDRONIC ZOLINZA ZYPREXACEREBRAL ATROPHY : Tysabri Side Effects Report #5650071-X
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Feb 21, 2008. Male patient, 43 years of age, weighting 182.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, multiple sclerosis, nuclear magnetic resonance imaging abnormal, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with VIAGRA, AMITRIPTYLINE, VESICARE. Patient recovered.
CEREBRAL ATROPHY : Avonex Side Effects Report #5657933-8
AVONEX problem was reported by a Health Professional from PERU on Feb 20, 2008. Male patient, 56 years of age, weighting 165.3 lb, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, hemiplegia, . AVONEX dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, AMLODIPINE, GLIBENCLAMIDE, METFORMIN, ACETYLSALICYLIC ACID. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Tysabri Side Effects Report #5664128-0
Health Professional from UNITED STATES reported TYSABRI problem on Mar 04, 2008. Male patient, 35 years of age, weighting 162.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, contusion, fall, hip fracture, thrombosis, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient died on 06/09/2007.
CEREBRAL ATROPHY : Clarith Side Effects Report #5665029-4
CLARITH problem was reported by a Physician from JAPAN on Mar 07, 2008. Female patient, 96 years of age, weighting 79.37 lb, was diagnosed with bronchitis, diabetes mellitus, dementia alzheimer's type, hypertension, reflux oesophagitis and was treated with CLARITH. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, hypoglycaemic coma, . CLARITH dosage: unknown. During the same period patient was treated with GLIMEPIRIDE, DONEPEZIL, AMLODIPINE BESYLATE, LANSOPRAZOLE, CLOPIDOGREL BISULPHATE. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Cisplatin Side Effects Report #5671178-7
Physician from UNITED STATES reported CISPLATIN problem on Mar 03, 2008. Male patient, 55 years of age, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, cerebral haemorrhage, coma, encephalitis herpes, immunosuppression, . CISPLATIN dosage: 60 MG/M2 /DAY 1 EVERY 28 DAYS. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient died.
CEREBRAL ATROPHY : Lorazepam Side Effects Report #5689670-8
LORAZEPAM problem was reported by a Health Professional from GERMANY on Mar 12, 2008. Female patient was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, fluid retention, . LORAZEPAM dosage: unknown. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Lorazepam Side Effects Report #5622219-4
Health Professional from GERMANY reported LORAZEPAM problem on Jan 22, 2008. Female patient was treated with LORAZEPAM. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, fluid retention, . LORAZEPAM dosage: unknown. Patient recovered.
CEREBRAL ATROPHY : Avonex Side Effects Report #5623804-6
AVONEX problem was reported by a Health Professional from PERU on Jan 23, 2008. Male patient, 56 years of age, weighting 165.3 lb, was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, hemiplegia, . AVONEX dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, AMLODIPINE, GLIBENCLAMIDE, METFORMIN. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Effexor Side Effects Report #5623986-6
Health Professional from FRANCE reported EFFEXOR problem on Feb 06, 2008. Male patient, weighting 134.5 lb, was diagnosed with major depression, pain, urinary incontinence and was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, cognitive disorder, confusional state, fall, hallucination, visual, mini mental status examination abnormal, restlessness, . EFFEXOR dosage: unknown. During the same period patient was treated with MOPRAL, NORSET, TRAMADOL, DRIPTANE, LASILIX, ACETAMINOPHEN, DIGOXIN. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Imipenem Side Effects Report #5627210-X
IMIPENEM AND CILASTATIN problem was reported by a Pharmacist from UNITED STATES on Feb 12, 2008. Male patient, 41 years of age, weighting 134.5 lb, was diagnosed with mycobacterium avium complex infection and was treated with IMIPENEM AND CILASTATIN. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, grand mal convulsion, . IMIPENEM AND CILASTATIN dosage: unknown. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Zyprexa Side Effects Report #5629361-2
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on Feb 05, 2008. Female patient, child 9 years of age, was diagnosed with hallucination, convulsion and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, csf test abnormal, intelligence test abnormal, . ZYPREXA dosage: 2.5 MG, UNK. During the same period patient was treated with ZYPREXA ZYDIS, DEPAKOTE, FOCALIN, TOPAMAX, CLONIDINE. Patient recovered.
CEREBRAL ATROPHY : Exelon Side Effects Report #5582631-9
EXELON PATCH problem was reported by a Health Professional from UNITED STATES on Dec 28, 2007. Female patient, 83 years of age, weighting 157.0 lb, was diagnosed with dementia alzheimer's type and was treated with EXELON PATCH. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, confusional state, mental status changes, nuclear magnetic resonance imaging abnormal, . EXELON PATCH dosage: 9.5 MG, QD. During the same period patient was treated with LEXAPRO, FOSAMAX, VYTORIN, ACETYLSALICYLIC ACID SRT, PATANOL, NAMENDA. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Sebivo Side Effects Report #5600945-0
Pharmacist from GERMANY reported SEBIVO problem on Jan 15, 2008. Female patient, 53 years of age, was diagnosed with hepatitis b and was treated with SEBIVO. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, cerebrovascular disorder, craniotomy, diplopia, nervous system disorder, visual acuity reduced, vith nerve paralysis, . SEBIVO dosage: 600 MG, Q96H. During the same period patient was treated with KELTICAN, RENAGEL, BICARBONATE, CINACALCET, ROCALTROL. Patient recovered.
CEREBRAL ATROPHY : Clozapine Side Effects Report #5553665-5
CLOZAPINE problem was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Dec 04, 2007. Female patient, 39 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, cerebral ventricle dilatation, dystonia, pleurothotonus, . CLOZAPINE dosage: UP TO 400 MG/DAY. During the same period patient was treated with VALPROIC ACID, VALPROIC ACID. Patient recovered.
CEREBRAL ATROPHY : Zoledronic Side Effects Report #5569370-5
Physician from UNITED KINGDOM reported ZOLEDRONIC ACID problem on Dec 20, 2007. Female patient, 83 years of age, weighting 96.12 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, cerebral ischaemia, cerebrovascular disorder, confusional state, contusion, disease progression, fall, haematoma, mobility decreased, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCICHEW D, SINEMET, ENTACAPONE, CABERGOLINE, OMEPRAZOLE, ASPIRIN, ACETAMINOPHEN. Patient was hospitalized and became disabled. Patient recovered.
CEREBRAL ATROPHY : Neoral Side Effects Report #5526653-2
NEORAL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 23, 2007. Male patient, 69 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, cerebral ischaemia, cerebrovascular accident, confusional state, dyspnoea, dyspnoea exertional, enterococcal infection, fall, increased upper airway secretion, . NEORAL dosage: 75 MG, BID. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Humulin Side Effects Report #5527739-9
Physician from JAPAN reported HUMULIN R problem on Nov 14, 2007. Female patient, 67 years of age, was treated with HUMULIN R. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, hypoglycaemic coma, hypoglycaemic encephalopathy, intentional overdose, suicide attempt, . HUMULIN R dosage: unknown. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Memantine Side Effects Report #5531274-1
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on Aug 30, 2007. Male patient, 78 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, cerebrovascular accident, fall, loss of consciousness, . MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, SOTALOL HYDROCHLORIDE, GLICLAZINE, FYBOGEL, SENNA, HYDROXOCOBALAMIN, DONEPEZIL, GALANTAMINE HYDROBROMIDE. Patient was hospitalized. Patient died on 06/30/2007.
CEREBRAL ATROPHY : Akarin Side Effects Report #5531602-7
Health Professional from DENMARK reported AKARIN problem on Nov 12, 2007. Male patient, 53 years of age, was diagnosed with depression and was treated with AKARIN. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, tremor, . AKARIN dosage: 60 MG QD PO. During the same period patient was treated with CYMBALTA. Patient recovered.
CEREBRAL ATROPHY : Gliadel Side Effects Report #5484858-3
GLIADEL problem was reported by a Physician from SPAIN on Dec 05, 2006. Male patient, 66 years of age, was diagnosed with glioblastoma multiforme and was treated with GLIADEL. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, convulsion, depression, . GLIADEL dosage: unknown. Patient recovered.
CEREBRAL ATROPHY : Carbatrol Side Effects Report #5492731-X
Physician from UNITED KINGDOM reported CARBATROL problem on Oct 05, 2007. Male patient, 40 years of age, was treated with CARBATROL. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, disease recurrence, encephalitis herpes, grand mal convulsion, hypogammaglobulinaemia, lymphopenia, memory impairment, scar, treatment noncompliance, . CARBATROL dosage: unknown. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Paroxetine Side Effects Report #5460760-8
PAROXETINE problem was reported by a Consumer or non-health professional from NETHERLANDS on Jan 28, 2004. Male patient was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, congenital neurological disorder, convulsion neonatal, glasgow coma scale abnormal, infantile apnoeic attack, intraventricular haemorrhage neonatal, thrombocytopenia neonatal, . PAROXETINE dosage: unknown. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Zyprexa Side Effects Report #5466767-9
Physician from FRANCE reported ZYPREXA problem on Sept 11, 2007. Male patient, 60 years of age, weighting 132.3 lb, was diagnosed with schizophrenia, paranoid type, blood pressure fluctuation, urinary tract disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, loss of consciousness, mania, overdose, . ZYPREXA dosage: 15 MG, DAILY (1/D). During the same period patient was treated with XANAX, DEPAKOTE, DIHYDROERGOTAMINE MESYLATE, DITROPAN. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Rebif Side Effects Report #5418044-X
REBIF problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Male patient, 50 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, cerebral infarction, cerebrovascular accident, cerebrovascular disorder, lacunar infarction, . REBIF dosage: unknown. During the same period patient was treated with ZOCOR, PLAVIX, DEPAKOTE, GLUCOPHAGE, AVANDIA. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Prograf Side Effects Report #5420278-5
Physician from JAPAN reported PROGRAF problem on July 31, 2007. Male patient, 42 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, convulsion, encephalitis, herpes simplex, human herpesvirus 6 infection, korsakoff's psychosis non-alcoholic, . PROGRAF dosage: unknown. Patient recovered.
CEREBRAL ATROPHY : Exelon Side Effects Report #5384285-3
EXELON problem was reported by a Physician from PANAMA on June 29, 2007. Female patient, 90 years of age, was diagnosed with senile dementia and was treated with EXELON. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, computerised tomogram abnormal, hydrocephalus, hyponatraemia, syncope, . EXELON dosage: 1.5 MG/D. During the same period patient was treated with ENALAPRIL MALEATE, INDAPAMIDE, PROZAC, LAMICTAL. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Ciprofloxacin Side Effects Report #5388371-3
Consumer or non-health professional from CHINA reported CIPROFLOXACIN problem on June 29, 2007. Male patient, 84 years of age, was diagnosed with infection and was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, dysarthria, dyskinesia, incorrect dose administered, lacunar infarction, renal impairment, tremor, . CIPROFLOXACIN dosage: 500MG, BID, ORAL. During the same period patient was treated with ASPIRIN, FRUSEMIDE, ALLOPURINOL, CARVEDILOL, IRBESARTAN. Patient was hospitalized and became disabled. Patient recovered.
CEREBRAL ATROPHY : Ciprofloxacin Side Effects Report #5390638-X
CIPROFLOXACIN problem was reported by a Consumer or non-health professional from CHINA on June 18, 2007. Male patient, 84 years of age, was diagnosed with laceration and was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, dysarthria, dyskinesia, neurotoxicity, overdose, renal impairment, treatment noncompliance, tremor, . CIPROFLOXACIN dosage: 2000,0 MG (500 MG, 4 IN 1 D). Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Zyprexa Side Effects Report #5391260-1
Consumer or non-health professional from FRANCE reported ZYPREXA problem on July 10, 2007. Female patient, 45 years of age, was diagnosed with psychotic disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, . ZYPREXA dosage: 10 MG, DAILY (1/D). Patient recovered.
CEREBRAL ATROPHY : Exelon Side Effects Report #5384285-3
EXELON problem was reported by a Physician from PANAMA on June 29, 2007. Female patient, 90 years of age, was diagnosed with senile dementia and was treated with EXELON. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, computerised tomogram abnormal, hydrocephalus, hyponatraemia, syncope, . EXELON dosage: 1.5 MG/D. During the same period patient was treated with ENALAPRIL MALEATE, INDAPAMIDE, PROZAC, LAMICTAL. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Ciprofloxacin Side Effects Report #5388371-3
Consumer or non-health professional from CHINA reported CIPROFLOXACIN problem on June 29, 2007. Male patient, 84 years of age, was diagnosed with infection and was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, dysarthria, dyskinesia, incorrect dose administered, lacunar infarction, renal impairment, tremor, . CIPROFLOXACIN dosage: 500MG, BID, ORAL. During the same period patient was treated with ASPIRIN, FRUSEMIDE, ALLOPURINOL, CARVEDILOL, IRBESARTAN. Patient was hospitalized and became disabled. Patient recovered.
CEREBRAL ATROPHY : Ciprofloxacin Side Effects Report #5390638-X
CIPROFLOXACIN problem was reported by a Consumer or non-health professional from CHINA on June 18, 2007. Male patient, 84 years of age, was diagnosed with laceration and was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, dysarthria, dyskinesia, neurotoxicity, overdose, renal impairment, treatment noncompliance, tremor, . CIPROFLOXACIN dosage: 2000,0 MG (500 MG, 4 IN 1 D). Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Zyprexa Side Effects Report #5391260-1
Consumer or non-health professional from FRANCE reported ZYPREXA problem on July 10, 2007. Female patient, 45 years of age, was diagnosed with psychotic disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, . ZYPREXA dosage: 10 MG, DAILY (1/D). Patient recovered.
CEREBRAL ATROPHY : Tysabri Side Effects Report #5676745-2
TYSABRI problem was reported by a Physician from UNITED STATES on Mar 03, 2008. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: agitation, cerebral atrophy, depression, international normalised ratio increased, lyme disease, multiple sclerosis relapse, pain, pulmonary embolism, urinary tract infection enterococcal, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Sebivo Side Effects Report #5620297-X
Pharmacist from GERMANY reported SEBIVO problem on Jan 29, 2008. Female patient, 52 years of age, weighting 104.7 lb, was diagnosed with hepatitis b and was treated with SEBIVO. After drug was administered, patient experienced the following problems/side effects: brain scan abnormal, cerebral atrophy, cerebrovascular disorder, craniotomy, diplopia, nervous system disorder, visual acuity reduced, vith nerve paralysis, . SEBIVO dosage: 600 MG, Q96H. During the same period patient was treated with KELTICAN, RENAGEL, BICARBONATE, CINACALCET, ROCALTROL. Patient recovered.
CEREBRAL ATROPHY : Cap Side Effects Report #5626958-0
CAP ZOLINZA problem was reported by a Consumer or non-health professional from DENMARK on Jan 29, 2008. Female patient, 77 years of age, was diagnosed with ovarian epithelial cancer recurrent and was treated with CAP ZOLINZA. After drug was administered, patient experienced the following problems/side effects: blood thyroid stimulating hormone increased, cerebral atrophy, constipation, dehydration, dizziness, dyspnoea, fibrin d dimer increased, hypermagnesaemia, nausea, . CAP ZOLINZA dosage: 100 MG/DAILY PO. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, MG OXIDE, METOCLOPRAMIDE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PREDNISOLONE. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Zolinza Side Effects Report #5636879-5
Consumer or non-health professional from DENMARK reported ZOLINZA problem on Feb 05, 2008. Female patient, 77 years of age, was diagnosed with ovarian epithelial cancer recurrent and was treated with ZOLINZA. After drug was administered, patient experienced the following problems/side effects: blood thyroid stimulating hormone increased, cerebral atrophy, constipation, dehydration, dizziness, dyspnoea, hypermagnesaemia, nausea, oral fungal infection, . ZOLINZA dosage: 100 MG/DAILY; PO. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, MG OXIDE, METOCLOPRAMIDE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PREDNISOLONE. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Paxil Side Effects Report #5640804-0
PAXIL problem was reported by a Physician from JAPAN on Feb 19, 2008. Male patient, 76 years of age, weighting 103.6 lb, was diagnosed with depression, intestinal polypectomy and was treated with PAXIL. After drug was administered, patient experienced the following problems/side effects: atrophy, cerebral atrophy, chest pain, depressed level of consciousness, disorientation, dyspnoea, epilepsy, eye movement disorder, fatigue, . PAXIL dosage: unknown. During the same period patient was treated with ALPRAZOLAM, MYSLEE, ITOROL, DILTIAZEM, VEEN F, ADONA, TRANSAMIN, GLUCAGON. Patient was hospitalized and became disabled. Patient recovered.
CEREBRAL ATROPHY : Antabuse Side Effects Report #5570044-5
Health Professional from SPAIN reported ANTABUSE problem on Nov 30, 2007. Male patient, 40 years of age, was diagnosed with alcoholism and was treated with ANTABUSE. After drug was administered, patient experienced the following problems/side effects: bradyphrenia, cerebral atrophy, coma, delirium, disorientation, encephalopathy, grand mal convulsion, oxygen saturation decreased, pneumonia aspiration, . ANTABUSE dosage: 250 MG, QD, ORAL. During the same period patient was treated with FOSAMPRENAVIR, TENOFOVIR, EMTRICITABINE. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Cacit Side Effects Report #5577667-8
CACIT D problem was reported by a Consumer or non-health professional from FRANCE on Dec 26, 2007. Female patient, 87 years of age, was diagnosed with sleep disorder, osteoporosis, pain in extremity, epilepsy and was treated with CACIT D. After drug was administered, patient experienced the following problems/side effects: blood osmolarity decreased, cerebral atrophy, computerised tomogram abnormal, epilepsy, fall, fluid intake restriction, glasgow coma scale abnormal, grand mal convulsion, head injury, . CACIT D dosage: unknown. During the same period patient was treated with MOVICOL, DIPROSONE, LACRIGEL, IMOVANE, ACTONEL, DOLIPRANE, DRIPTANE, TRILEPTAL. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Citalopram Side Effects Report #5512344-0
Health Professional from SWITZERLAND reported CITALOPRAM HYDROBROMIDE problem on Oct 23, 2007. Male patient, 60 years of age, weighting 207.2 lb, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: asphyxia, cerebral atrophy, completed suicide, mental disorder, pulmonary embolism, suicide attempt, . CITALOPRAM HYDROBROMIDE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, EFFEXOR, AKINETON, MARCUMAR. Patient died on 01/13/2007.
CEREBRAL ATROPHY : Cisplatin Side Effects Report #5515883-1
CISPLATIN problem was reported by a Health Professional from ITALY on Oct 29, 2007. Male patient, 55 years of age, was diagnosed with prophylaxis and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: brain oedema, cerebral atrophy, cerebral haemorrhage, coma, encephalitis herpes, hypogammaglobulinaemia, immunosuppression, leukocytosis, lymphopenia, . CISPLATIN dosage: 4 CYCLES, 1 CYCLE EVERY 28 DAYS, 60 MG/M2 ON DAY 1 EVERY 28 DAYS, 2 CYCLES. During the same period patient was treated with ETOPOSIDE, DEXAMETHASONE, IRRADIATION. Patient died.
CEREBRAL ATROPHY : Isoniazid Side Effects Report #5531297-2
Physician from INDIA reported ISONIAZID problem on Nov 14, 2007. Male patient, 57 years of age, was diagnosed with lymphadenopathy and was treated with ISONIAZID. After drug was administered, patient experienced the following problems/side effects: cerebellar syndrome, cerebral atrophy, dysarthria, gait disturbance, haemoglobin decreased, tremor, . ISONIAZID dosage: 300 MG ; 100 MG/DAY THEN INCREASED TO 200 MG/DAY (REINTRODUCTION). During the same period patient was treated with RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE, PYRAZINAMIDE, PYRIDOXINE. Patient recovered.
CEREBRAL ATROPHY : Escitalopram Side Effects Report #5531684-2
ESCITALOPRAM problem was reported by a Health Professional from GERMANY on Nov 12, 2007. Female patient, 70 years of age, was diagnosed with major depression and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: balance disorder, cerebral atrophy, cerebral ischaemia, condition aggravated, depression, gait disturbance, masked facies, psychomotor retardation, . ESCITALOPRAM dosage: 20 MG QD PO. During the same period patient was treated with MIRTAZAPINE, LORAZEPAM, ZYPREXA, ENALAPRIL, AMLODIPINE. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Cipramil Side Effects Report #5532167-6
Health Professional from DENMARK reported CIPRAMIL problem on Nov 12, 2007. Female patient, 69 years of age, was diagnosed with depression, major depression, psychotic disorder and was treated with CIPRAMIL. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebral atrophy, depression, fear, microangiopathy, parkinsonism, psychotic disorder, . CIPRAMIL dosage: 20 MG QD PO. During the same period patient was treated with SEROQUEL, MADOPAR. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Citalopram Side Effects Report #5482080-8
CITALOPRAM HYDROBROMIDE problem was reported by a Health Professional from DENMARK on Sept 20, 2007. Male patient, 60 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: asphyxia, cerebral atrophy, completed suicide, mental disorder, pulmonary embolism, . CITALOPRAM HYDROBROMIDE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, EFFEXOR, AKINETON, MARCUMAR. Patient was hospitalized. Patient died on 01/13/2007.
CEREBRAL ATROPHY : Betaseron Side Effects Report #5501023-1
Health Professional from UNITED STATES reported BETASERON problem on Oct 15, 2007. Female patient, 71 years of age, weighting 150.0 lb, was diagnosed with relapsing-remitting multiple sclerosis, urinary incontinence and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: bladder spasm, cerebral atrophy, cerebral infarction, escherichia urinary tract infection, hemiparesis, lung neoplasm malignant, multiple sclerosis, syncope vasovagal, . BETASERON dosage: unknown. During the same period patient was treated with LEVAQUIN, SYNTHROID, NEURONTIN, ZOCOR, LISINOPRIL, ZOLOFT, DETROL. Patient was hospitalized. Patient died on 01/15/2007.
CEREBRAL ATROPHY : Prograf Side Effects Report #5453556-4
PROGRAF problem was reported by a Physician from JAPAN on Aug 28, 2007. Male patient, 41 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: amnesia, cerebral atrophy, encephalitis herpes, human herpesvirus 6 infection, hyponatraemia, infection in an immunocompromised host, insomnia, pancytopenia, pseudomembranous colitis, . PROGRAF dosage: 2 MG, D, IV DRIP. During the same period patient was treated with LIPOVAS, LORAZEPAM, ALLOPURINOL, JUSO, ZOVIRAX, DIFLUCAN, CIPROXAN, OMEPRALLET. Patient recovered.
CEREBRAL ATROPHY : Altace Side Effects Report #5466672-8
Consumer or non-health professional from FRANCE reported ALTACE problem on Sept 17, 2007. Female patient was diagnosed with essential hypertension, hiccups, ischaemic cardiomyopathy and was treated with ALTACE. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebral atrophy, confusional state, disorientation, hyponatraemia, loss of proprioception, mini mental status examination abnormal, speech disorder, transient ischaemic attack, . ALTACE dosage: 2.5 MG, QD. During the same period patient was treated with PRIMPERAN, TEMESTA, MEDIATENSYL, BISOPROLOL, PLAVIX, KARDEGIC. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Memantine Side Effects Report #5466864-8
MEMANTINE problem was reported by a Health Professional from FRANCE on Aug 13, 2007. Male patient, 85 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood urea increased, cerebral atrophy, dehydration, rhabdomyolysis, . MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, RISPERDAL. Patient was hospitalized. Patient recovered.
CEREBRAL ATROPHY : Prezista Side Effects Report #5405001-2
Physician from UNITED STATES reported PREZISTA problem on July 24, 2007. Male patient, 48 years of age, was diagnosed with hiv infection and was treated with PREZISTA. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, cerebral atrophy, . PREZISTA dosage: unknown. During the same period patient was treated with PROTONIX, ZYVOX, TRUVADA, NAPROXEN, IMODIUM, ACIPHEX, HYZAAR. Patient was hospitalized. Patient recovered.